Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Medical Physics|October 10, 2008
Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working GroupWayne M Butler, William S Bice, Larry A DeWerd, et al.
American Journal of Clinical Oncology|November 22, 2011
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancerBrian J Moran, Paul DeRose, I-Chow Joe Hsu, et al.
Oncology (Williston Park, N.Y.)|December 17, 2014
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancerGary S Gustafson, Paul L Nguyen, Dean G Assimos, et al.
Brachytherapy|February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank, Peter D Grimm, John E Sylvester, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium StudyKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA|March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate CancerAmar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium AnalysisSagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
European Urology|April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective AnalysisKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
European Urology|May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate CancerRebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
JAMA Oncology|January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 CohortsAmar U Kishan, Alison Steigler, James W Denham, et al.
Pageof 19